Exploring fungal survival mechanisms: toward next-generation antifungal therapies against Candida spp.

Medicine and Dentistry

• Antifungal Agent 100%
• Antifungal Therapy 100%
• Biosynthesis 66%
• Oxidative Stress 33%
• Pathogen 33%
• Immune Response 33%
• Infection 33%
• Systemic Disease 33%
• Synapsin I 33%
• Cell Membrane 33%
• Quorum Sensing 33%
• Virulence Factor 33%
• Pathogenicity 33%
• Amino Acid 33%
• Clinical Research 33%
• Extracellular Matrix 33%
• Translating (Language) 33%
• Mucocutaneous Candidiasis 33%
• Calcineurin 33%
• Glucan 33%
• Phospholipase 33%
• Antifungal Resistance 33%
• Chitin 33%
• Immunomodulation 33%
• Fungal Cell Wall 33%
• Ergosterol 33%
• Aspartic Proteinase 33%
• Glyoxylic Acid 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Candida 100%
• Antifungal Therapy 100%
• Antifungal Agent 66%
• Resistance to Antifungal Agent 66%
• Infectious Agent 33%
• Infection 33%
• Drug Development 33%
• Virulence Factor 33%
• Pathogenicity 33%
• Systemic Disease 33%
• Amino Acid 33%
• Synapsin I 33%
• Clinical Research 33%
• Glucan 33%
• Aspartic Proteinase 33%
• Chitin 33%

Immunology and Microbiology

• Candida 100%
• Biosynthesis 66%
• Virulence Factor 33%
• Pathogenicity 33%
• Quorum Sensing 33%
• Infectious Agent 33%
• Oxidative Stress 33%
• Biofilm 33%
• Immunomodulation 33%
• Amino Acid 33%
• Infectious Disease 33%
• Host Immune Response 33%
• Cell Membrane 33%
• Extracellular Matrix 33%
• Infection 33%
• Fungal Cell Wall 33%
• Protease 33%
• Antifungal Resistance 33%